Category: Drug Discovery
Drug Discovery market research reports by Icon Group International, Inc.
-
The 2025-2030 World Outlook for Leukemia Chemotherapy Therapeutics
The 2025-2030 World Outlook for Leukemia Chemotherapy Therapeutics This study covers the world outlook for leukemia chemotherapy therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in ... Read More
-
The 2025-2030 World Outlook for HIV-1 Therapeutics
The 2025-2030 World Outlook for HIV-1 Therapeutics This study covers the world outlook for HIV-1 therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. d ... Read More
-
The 2025-2030 World Outlook for Rare Disease Drugs
The 2025-2030 World Outlook for Rare Disease Drugs This study covers the world outlook for rare disease drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. d ... Read More
-
The 2025-2030 World Outlook for Peptic Ulcer Drugs
The 2025-2030 World Outlook for Peptic Ulcer Drugs This study covers the world outlook for peptic ulcer drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. d ... Read More
-
The 2025-2030 World Outlook for Healthcare Nanotechnology and Nanomedicine Therapeutics
The 2025-2030 World Outlook for Healthcare Nanotechnology and Nanomedicine Therapeutics This study covers the world outlook for healthcare nanotechnology and nanomedicine therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential indu ... Read More
-
The 2025-2030 World Outlook for Insomnia Therapeutics
The 2025-2030 World Outlook for Insomnia Therapeutics This study covers the world outlook for insomnia therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of ... Read More
-
The 2025-2030 World Outlook for Respiratory Complications Therapeutics
The 2025-2030 World Outlook for Respiratory Complications Therapeutics This study covers the world outlook for respiratory complications therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the co ... Read More
-
The 2025-2030 World Outlook for Inflammatory Bowel Disease Therapeutics
The 2025-2030 World Outlook for Inflammatory Bowel Disease Therapeutics This study covers the world outlook for inflammatory bowel disease therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the ... Read More
-
The 2025-2030 World Outlook for Urology Drugs
The 2025-2030 World Outlook for Urology Drugs This study covers the world outlook for urology drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), t ... Read More
-
The 2025-2030 World Outlook for Progressive Multifocal Leukoencephalopathy Treatments
The 2025-2030 World Outlook for Progressive Multifocal Leukoencephalopathy Treatments This study covers the world outlook for progressive multifocal leukoencephalopathy treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry ... Read More
-
The 2025-2030 World Outlook for Adult Malignant Glioma Therapeutics
The 2025-2030 World Outlook for Adult Malignant Glioma Therapeutics This study covers the world outlook for adult malignant glioma therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country ... Read More
Research Assistance
